Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
Clinical trial NCT00004852 · COMPLETED
Trial details
- NCT number
- NCT00004852
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.